4//SEC Filing
HEIDEN WILLIAM K 4
Accession 0001140361-22-024165
CIK 0001604464other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:48 PM ET
Size
6.7 KB
Accession
0001140361-22-024165
Insider Transaction Report
Form 4
HEIDEN WILLIAM K
Director
Transactions
- Award
Non-Qualified Stock Option (Right to Buy)
2022-06-23+31,500→ 31,500 totalExercise: $7.35Exp: 2032-06-22→ Common Stock (31,500 underlying) - Award
Common Stock
2022-06-23+20,500→ 52,000 total
Footnotes (2)
- [F1]These restricted stock units shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
- [F2]The option shall vest on the earlier of June 23, 2023 or the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service.
Documents
Issuer
Atara Biotherapeutics, Inc.
CIK 0001604464
Entity typeother
Related Parties
1- filerCIK 0001214939
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:48 PM ET
- Size
- 6.7 KB